col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


127 Results       Page 1

 [1] 
American Society for Clinical Investigation: Journal of Clinical Investigation
  original article Date Title Authors   All Authors
1 [GO] 2022―May―10 Favorable vaccine-induced SARS-CoV-2 specific T cell response profile in patients undergoing immune-modifying therapies Martin Qui, Nina Le Bert, Webber Pak Wo Chan, Malcolm Tan, Shou Kit Hang, Smrithi Hariharaputran, et al. (+7)
2 [GO] 2022―Apr―28 Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response Maddalena Marconato, Irene A. Abela, Anthony Hauser, Magdalena Schwarzmüller, Rheliana Katzensteiner, Dominique L. Braun, et al. (+17)
3 [GO] 2022―Apr―26 An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, Elad Binshtein, Rita E. Chen, James Brett Case, et al. (+15)
4 [GO] 2022―Mar―22 A multitope SARS-COV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, Wen-Jiun Peng, Yea-Huei Shen, Be-Sheng Kuo, et al. (+44)
5 [GO] 2022―Mar―08 Vaccine-breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota and Omicron Brenda Martínez-González, Lucía Vázquez-Sirvent, María E. Soria, Pablo Mínguez, Llanos Salar-Vidal, Carlos García-Crespo, et al. (+13)
6 [GO] 2022―Feb―09 Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2 Elena Mitsi, Jesús Reiné, Britta C. Urban, Carla Solorzano, Elissavet Nikolaou, Angela D. Hyder-Wright, et al. (+24)
7 [GO] 2022―Feb―09 SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies Alessio Mazzoni, Anna Vanni, Michele Spinicci, Giulia Lamacchia, Seble Tekle Kiros, Arianna Rocca, et al. (+15)
8 [GO] 2022―Feb―02 Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance Jia Zou, Li Li, Peiyi Zheng, Wenhua Liang, Siyi Hu, Shuaixiang Zhou, et al. (+28)
9 [GO] 2022―Jan―21 CD4+ T-cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses Bezawit A. Woldemeskel, Arbor G. Dykema, Caroline Garliss, Saphira Cherfils, Kellie N. Smith, Joel N. Blankson
10 [GO] 2021―Dec―29 Platelets mediate inflammatory monocyte activation by SARS-CoV-2 Spike protein Tianyang Li, Yang Yang, Yongqi Li, Zhengmin Wang, Faxiang Ma, Runqi Luo, et al. (+7)
11 [GO] 2021―Dec―14 The Journal of Clinical Investigation in the time of COVID-19 Arturo Casadevall, Sarah Jackson, Gregg L. Semenza, Gordon F. Tomaselli, Rexford S. Ahima
12 [GO] 2021―Dec―14 Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. Reply. Anthony T. Tan, Nina Le Bert, Antonio Bertoletti
13 [GO] 2021―Dec―14 Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions Rory D. de Vries, Marieke van der Heiden, Daryl Geers, Celine Imhof, Debbie van Baarle
14 [GO] 2021―Dec―06 Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome David S. Perlin, Garry A. Neil, Colleen Anderson, Inbal Zafir-Lavie, Shane Raines, Carl F. Ware, H. Jeffrey Wilkins
15 [GO] 2021―Nov―29 SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralising antibodies Anna Jeffery-Smith, Alice R. Burton, Sabela Lens, Chloe Rees-Spear, Jessica Davies, Monika Patel, et al. (+9)
16 [GO] 2021―Nov―17 A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia Katharine J. Bar, Pamela A. Shaw, Grace H. Choi, Nicole Aqui, Andrew Fesnak, Jasper B. Yang, et al. (+34)
17 [GO] 2021―Nov―14 Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone Peter J. Siska, Sonja-Maria Decking, Nathalie Babl, Carina Matos, Christina Bruss, Katrin Singer, et al. (+40)
18 [GO] 2021―Nov―09 Family matters for coronavirus disease and vaccines David J. Bean, Manish Sagar
19 [GO] 2021―Oct―31 NK cell receptor and ligand composition influences the clearance of SARS-CoV-2 Wan-Chen Hsieh, En-Yu Lai, Yu-Ting Liu, Yi-Fu Wang, Yi-Shiuan Tzeng, Lu Cui, et al. (+22)
20 [GO] 2021―Oct―28 The intersection of COVID-19 and autoimmunity Jason S. Knight, Roberto Caricchio, Jean Laurent Casanova, Alexis J. Combes, Betty Diamond, Sharon E. Fox, et al. (+13)
21 [GO] 2021―Oct―21 Will GWAS eventually allow the identification of genomic biomarkers for COVID-19 severity and mortality? Vito Luigi Colona, Michela Bianocolella, Antonio Novelli, Giuseppe Novelli
22 [GO] 2021―Oct―08 Cross-protective immunity following coronavirus vaccination and coronavirus infection Tanushree Dangi, Nicole Palacio, Sarah Sanchez, Mincheol Park, Jake Class, Lavanya Visvabharathy, et al. (+4)
23 [GO] 2021―Oct―07 SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women Adeel A. Butt, Hiam Chemaitelly, Abdullatif Al Khal, Peter V Coyle, Huda Saleh, Anvar Kaleeckal, et al. (+4)
24 [GO] 2021―Oct―01 Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality Tomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, Mattia Cordioli, Guillaume Butler-Laporte, Douglas Maya-Miles, et al. (+41)
25 [GO] 2021―Sep―30 Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine Ofer Beharier, Romina Plitman Mayo, Tal Raz, Kira Nahum Sacks, Letizia Schreiber, Yael Suissa-Cohen, et al. (+18)
26 [GO] 2021―Sep―14 Physician-scientists in the pandemic era: tidal wave or rising tide? Lorraine B. Ware
27 [GO] 2021―Sep―09 Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients Muriel Aguilar-Bretones, Brenda M. Westerhuis, Matthijs P. Raadsen, Erwin de Bruin, Felicity D. Chandler, Nisreen M.A. Okba, et al. (+12)
28 [GO] 2021―Sep―02 A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia Cristina Avendaño-Solá, Antonio Ramos-Martínez, Elena Muñez-Rubio, Belen Ruiz-Antorán, Rosa Malo de Molina, Ferran Torres, et al. (+31)
29 [GO] 2021―Aug―31 Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19 Shanna A. Arnold Egloff, Angela Junglen, Joseph S.A. Restivo, Marjorie Wongskhaluang, Casey Martin, Pratik Doshi, et al. (+6)
30 [GO] 2021―Aug―31 Results of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients Sixten Körper, Manfred Weiss, Daniel Zickler, Thomas Wiesmann, Kai Zacharowski, Victor M. Corman, et al. (+21)
31 [GO] 2021―Aug―31 Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals Anthony T. Tan, Joey M.E. Lim, Nina Le Bert, Kamini Kunasegaran, Adeline Chia, Martin D.C. Qui, et al. (+12)
32 [GO] 2021―Aug―27 Attenuated activation of pulmonary immune cells in mRNA-1273 vaccinated hamsters after SARS-CoV-2 infection Michelle Meyer, Yuan Wang, Darin Edwards, Gregory R. Smith, Aliza B. Rubenstein, Palaniappan Ramanathan, et al. (+22)
33 [GO] 2021―Aug―19 Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19 Ravindra Ganesh, Colin F. Pawlowski, John C. O'Horo, Lori L. Arndt, Richard F. Arndt, Sarah Bell, et al. (+14)
34 [GO] 2021―Aug―19 Association of in-hospital use of ACE-I/ARB and COVID-19 outcomes in African American population Shilong Li, Rangaprasad Sarangarajan, Tomi Jun, Yu-Han Kao, Zichen Wang, Ke Hao, et al. (+7)
35 [GO] 2021―Aug―17 Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality Justin M. Snider, Jeehyun Karen You, Xia Wang, Ashley J. Snider, Brian Hallmark, Manja M. Zec, et al. (+18)
36 [GO] 2021―Aug―10 Dominance of alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City Ralf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Guiqing Wang, Jennifer Lighter, et al. (+3)
37 [GO] 2021―Jul―14 Distinctive features of severe SARS-CoV-2 pneumonia G.R. Scott Budinger, Alexander V. Misharin, Karen M. Ridge, Benjamin D. Singer, Richard G. Wunderink
38 [GO] 2021―Jun―30 SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes Yijia Li, Alexis M. Schneider, Arnav Mehta, Moshe Sade-Feldman, Kyle R. Kays, Matteo Gentili, et al. (+24)
39 [GO] 2021―Jun―24 Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia Qian Zhang, Aurélie Cobat, Paul Bastard, Luigi D. Notarangelo, Helen C. Su, Laurent Abel, Jean-Laurent Casanova
40 [GO] 2021―Jun―22 Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. Reply Gundula Povysil, Guillaume Butler-Laporte, Ali G. Gharavi, J. Brent Richards, David B. Goldstein, Krzysztof Kiryluk
41 [GO] 2021―Jun―18 Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid organ transplant recipients Peter G. Stock, Timothy J. Henrich, Dorry L. Segev, William A. Werbel
42 [GO] 2021―Jun―08 Impaired humoral and cellular immunity after SARS-CoV2 BNT162b2 (Tozinameran) prime-boost vaccination in kidney transplant recipients Arne Sattler, Eva Schrezenmeier, Ulrike A. Weber, Alexander Potekhin, Friederike Bachmann, Henriette Straub-Hohenbleicher, et al. (+19)
43 [GO] 2021―Jun―01 Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D Jian Zheng, David Meyerholz, Lok-Yin Roy Wong, Michael Gelb, Makoto Murakami, Stanley Perlman
44 [GO] 2021―Jun―01 Mild COVID-19 despite autoantibodies to type I IFNs in Autoimmune-Polyendocrine-Syndrome Type 1 (APS-1) Christian Meisel, Bengisu Akbil, Tim Meyer, Erwin Lankes, Victor M. Corman, Olga Staudacher, et al. (+8)
45 [GO] 2021―Jun―01 Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19? Chris Cotsapas, Janna Saarela, Jocelyn R. Farmer, Vinod Scaria, Roshini S. Abraham
46 [GO] 2021―May―27 Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19 Gundula Povysil, Guillaume Butler-Laporte, Ning Shang, Chen Wang, Atlas Khan, Manal Alaamery, et al. (+46)
47 [GO] 2021―May―21 Mounting evidence for immunizing previously infected subjects with a single dose of SARS-CoV-2 vaccine Gonzalo Perez Marc, Damian Alvarez-Paggi, Fernando P. Polack
48 [GO] 2021―May―20 Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine Ofer Beharier, Romina Plitman Mayo, Tal Raz, Kira Nahum Sacks, Letizia Schreiber, Yael Suissa-Cohen, et al. (+18)
49 [GO] 2021―May―18 Nasal ciliated cells are primary targets for SARS-CoV-2 replication in early stage of COVID-19 Ji Hoon Ahn, JungMo Kim, Seon Pyo Hong, Sung Yong Choi, Myung Jin Yang, Young Seok Ju, et al. (+8)
50 [GO] 2021―May―11 A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 Max R. O'Donnell, Beatriz Grinsztejn, Matthew J. Cummings, Jessica E. Justman, Matthew R. Lamb, Christina M. Eckhardt, et al. (+36)
51 [GO] 2021―May―11 What should define a SARS-CoV-2 “breakthrough” infection? John S. Schieffelin, Elizabeth B. Norton, Jay K. Kolls
52 [GO] 2021―May―06 One dose of SARS-CoV-2 vaccine exponentially increases antibodies in recovered individuals with symptomatic COVID-19 Riccardo Levi, Elena Azzolini, Chiara Pozzi, Leonardo Ubaldi, Michele Lagioia, Alberto Mantovani, Maria Rescigno
53 [GO] 2021―May―04 Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and Tuberculosis co-infection Catherine Riou, Elsa Du Bruyn, Cari Stek, Remy Daroowala, Rene T. Goliath, Fatima Abrahams, et al. (+8)
54 [GO] 2021―May―04 Is complement the culprit behind COVID-19 vaccine-related adverse reactions? Dimitrios C. Mastellos, Panagiotis Skendros, John D. Lambris
55 [GO] 2021―May―03 First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in recovered COVID-19 subjects Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi, Lorenzo Salvati, Anna Vanni, Manuela Capone, et al. (+16)
56 [GO] 2021―Apr―12 SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children (MIS-C) Theodore Kouo, Worarat Chaisawangwong
57 [GO] 2021―Apr―12 Structure-based phylogeny identifies Avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in mice Young Joo Sun, Gabriel Velez, Dylan E. Parsons, Kun Li, Miguel E. Ortiz, Shaunik Sharma, et al. (+3)
58 [GO] 2021―Apr―08 Functional characterization of CD4+ T-cell receptors cross-reactive for SARS-CoV-2 and endemic coronaviruses Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, Caroline C. Garliss, Laurene S. Cheung, Dilshad Choudhury, et al. (+22)
59 [GO] 2021―Apr―06 SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63 Bezawit A. Woldemeskel, Caroline C. Garliss, Joel N. Blankson
60 [GO] 2021―Mar―16 A sobering addition to the literature on COVID-19 and the brain Amit Mahajan, Graeme F. Mason
61 [GO] 2021―Feb―26 Identification of SARS-CoV-2-specific immune alterations in acutely ill patients Rose-Marie Rébillard, Marc Charabati, Camille Grasmuck, Abdelali Filali-Mouhim, Olivier Tastet, Nathalie Brassard, et al. (+32)
62 [GO] 2021―Feb―25 Long-term micro-structure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations Yuanyuan Qin, Jinfeng Wu, Tao Chen, Jia Li, Guiling Zhang, Di Wu, et al. (+8)
63 [GO] 2021―Feb―23 SARS-Cov2 variants and convalescent plasma: reality, fallacies, and opportunities Arturo Casadevall, Jeffrey Henderson, Michael Joyner, Liise-anne Pirofski
64 [GO] 2021―Feb―11 Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality William R. Morgenlander, Stephanie N. Henson, Daniel R. Monaco, Athena Chen, Kirsten Littlefield, Evan M. Bloch, et al. (+23)
65 [GO] 2021―Feb―11 Durable SARS-CoV-2 B cell immunity after mild or severe disease Clinton O. Ogega, Nicole E. Skinner, Paul W. Blair, Han-Sol Park, Kirsten Littlefield, Abhinaya Ganesan, et al. (+10)
66 [GO] 2021―Feb―09 Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection Zhen Huang, Bo Ning, He S. Yang, Brady M. Youngquist, Alex Niu, Christopher J. Lyon, et al. (+19)
67 [GO] 2021―Feb―01 The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity Hamid Bolouri, Cate Speake, David Skibinski, S. Alice Long, Anne M. Hocking, Daniel J. Campbell, et al. (+3)
68 [GO] 2021―Jan―26 Similarities and differences between the immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome and Kawasaki disease Ana Esteve-Sole, Jordi Anton, Rosa Maria Pino-Ramírez, Judith Sanchez-Manubens, Victoria Fumadó, Clàudia Fortuny, et al. (+17)
69 [GO] 2021―Jan―26 Severe SARS-CoV-2 placenta infection can impact neonatal outcome in the absence of vertical transmission Fulvia Milena Cribié, Roberta Erra, Lorenza Pugni, Carlota Rubio-Perez, Lidia Alonso, Sara Simonetti, et al. (+16)
70 [GO] 2021―Jan―25 Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity Sara Falck-Jones, Sindhu Vangeti, Meng Yu, Ryan Falck-Jones, Alberto Cagigi, Isabella Badolati, et al. (+16)
71 [GO] 2021―Jan―14 COVID-19 vaccine testing in pregnant females is necessary Sabra L. Klein, Patrick S. Creisher, Irina Burd
72 [GO] 2021―Jan―11 SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals Hassen Kared, Andrew D. Redd, Evan M. Bloch, Tania S. Bonny, Hermi R. Sumatoh, Faris Kairi, et al. (+16)
73 [GO] 2020―Dec―15 Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 among COVID-19 convalescent plasma donor candidates Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Danniel Zamora, Sarah A. McGuffin, Adrienne E. Shapiro, et al. (+19)
74 [GO] 2020―Dec―11 BCG vaccination in healthcare providers and the protection against COVID-19 Mihai G. Netea, Jos W.M. van der Meer, Reinout van Crevel
75 [GO] 2020―Nov―20 Does common cold coronavirus infection protect against severe SARS-CoV2 disease? David K. Meyerholz, Stanley Perlman
76 [GO] 2020―Nov―20 SARS-CoV-2 B cell receptor signatures in risk populations Andrew I. Flyak
77 [GO] 2020―Nov―19 BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers Magali Noval Rivas, Joseph E. Ebinger, Min Wu, Nancy Sun, Jonathan Braun, Kimia Sobhani, et al. (+3)
78 [GO] 2020―Nov―12 Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium Bryce A. Schuler, A. Christian Habermann, Erin J. Plosa, Chase J. Taylor, Christopher Jetter, Nicholas M. Negretti, et al. (+13)
79 [GO] 2020―Nov―10 Emergency seed funding for COVID-19 research: lessons from Johns Hopkins University Julie Messersmith, Chasmine Stoddart-Osumah, Marc Lennon, Denis Wirtz
80 [GO] 2020―Nov―02 Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome Jiao Liu, Sheng Zhang, Xuan Dong, Zhongyi Li, Qianghong Xu, Huibin Feng, et al. (+14)
81 [GO] 2020―Oct―29 Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection Jacob K. Files, Sushma Boppana, Mildred D. Perez, Sanghita Sarkar, Kelsey E. Lowman, Kai Qin, et al. (+9)
82 [GO] 2020―Oct―27 Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum Jill E. Weatherhead, Eva H. Clark, Tiphanie P. Vogel, Robert L. Atmar, Prathit A. Kulkarni
83 [GO] 2020―Oct―26 Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity? Philip A. Mudd, Kenneth E. Remy
84 [GO] 2020―Oct―21 Age-related susceptibility to Coronavirus infections: role of impaired and dysregulated host immunity Rudragouda Channappanavar, Stanley Perlman
85 [GO] 2020―Oct―16 SARS-CoV-2 specific antibody rearrangements in pre-pandemic immune repertoires of risk cohorts and COVID-19 patients Lisa Paschold, Donjete Simnica, Edith Willscher, Maria J.G.T. Vehreschild, Jochen Dutzmann, Daniel G. Sedding, et al. (+2)
86 [GO] 2020―Oct―15 What are protective antibody responses to pandemic SARS-CoV-2? Jeffrey P. Henderson
87 [GO] 2020―Oct―06 COVID-19 and myeloid cells: complex interplay correlates with lung severity Franco R. D'Alessio, Nicola M. Heller
88 [GO] 2020―Sep―30 Recent endemic coronavirus infection is associated with less severe COVID-19 Manish Sagar, Katherine Reifler, Michael Rossi, Nancy S. Miller, Pranay Sinha, Laura White, Joseph P. Mizgerd
89 [GO] 2020―Sep―29 COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain Massimiliano Secchi, Elena Bazzigaluppi, Cristina Brigatti, Ilaria Marzinotto, Cristina Tresoldi, Patrizia Rovere-Querini, et al. (+7)
90 [GO] 2020―Sep―25 Corticosteroids, COVID-19 pneumonia and acute respiratory distress syndrome Michael A. Matthay, Katherine D. Wick
91 [GO] 2020―Sep―25 Are T cells helpful for COVID-19: the relationship between response and risk Diane E. Griffin
92 [GO] 2020―Sep―23 Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2 Bezawit A. Woldemeskel, Abena K. Kwaa, Caroline C. Garliss, Oliver Laeyendecker, Stuart C. Ray, Joel N. Blankson
93 [GO] 2020―Sep―15 Drugs of unproven benefit for COVID-19: a pharma perspective on ethical allocation of available therapies Arthur L. Caplan, Joanne Waldstreicher, Karla Childers, Aran Maree
94 [GO] 2020―Sep―14 Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology Berhane Ghebrehiwet, Ellinor I. Peerschke
95 [GO] 2020―Sep―09 Caring for patients in a new pandemic: the necessity and challenges of observational research David L. Thomas
96 [GO] 2020―Sep―08 Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation Gunjan L. Shah, Susan DeWolf, Yeon Joo Lee, Roni Tamari, Parastoo B. Dahi, Jessica A. Lavery, et al. (+22)
97 [GO] 2020―Sep―01 Immune pathogenesis of COVID-19-related Multisystem Inflammatory Syndrome in Children (MIS-C) Anne H. Rowley, Stanford T. Shulman, Moshe Arditi
98 [GO] 2020―Aug―25 Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals Fang Gong, Yaping Dai, Ting Zheng, Liang Cheng, Dan Zhao, Hao Wang, et al. (+5)
99 [GO] 2020―Aug―24 SARS-CoV-2 specific T-cell responses and correlations with COVID-19 patient predisposition Arne Sattler, Stefan Angermair, Helena Stockmann, Katrin Moira Heim, Dmytro Khadzhynov, Sascha Treskatsch, et al. (+3)
100 [GO] 2020―Aug―18 Baricitinib restrains the immune dysregulation in severe COVID-19 patients Vincenzo Bronte, Stefano Ugel, Elisa Tinazzi, Antonio Vella, Francesco De Sanctis, Stefania Canè, et al. (+24)
101 [GO] 2020―Aug―12 COVID-19 severity associates with pulmonary redistribution of CD1c+ DC and inflammatory transitional and nonclassical monocytes Ildefonso Sánchez-Cerrillo, Pedro Landete, Beatriz Aldave, Santiago Sánchez-Alonso, Ana Sánchez-Azofra, Ana Marcos-Jiménez, et al. (+18)
102 [GO] 2020―Aug―07 Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population Sabra L. Klein, Andrew Pekosz, Han-Sol Park, Rebecca L. Ursin, Janna R. Shapiro, Sarah E. Benner, et al. (+17)
103 [GO] 2020―Aug―06 Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis Panagiotis Skendros, Alexandros Mitsios, Akrivi Chrysanthopoulou, Dimitrios C. Mastellos, Simeon Metallidis, Petros Rafailidis, et al. (+11)
104 [GO] 2020―Aug―03 Toward better preparedness for the next pandemic Lauren I. Shapiro, Grace R. Kajita, Julia H. Arnsten, Yaron Tomer
105 [GO] 2020―Jul―30 Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2 Caroline Diorio, Sarah E. Henrickson, Laura A. Vella, Kevin O. McNerney, Julie M. Chase, Chakkapong Burudpakdee, et al. (+31)
106 [GO] 2020―Jul―30 COVID-19, racism, and the pursuit of health care and research worthy of trust Lisa A. Cooper, Deidra C. Crews
107 [GO] 2020―Jul―23 Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children Pui Y. Lee, Megan Day-Lewis, Lauren A. Henderson, Kevin Friedman, Jeffrey Lo, Jordan E. Roberts, et al. (+23)
108 [GO] 2020―Jul―21 Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City Roy M. Gulick, Magdalena E. Sobieszczyk, Donald W. Landry, Anthony N. Hollenberg
109 [GO] 2020―Jul―07 Kinetics of viral load and antibody response in relation to COVID-19 severity Yanqun Wang, Lu Zhang, Ling Sang, Feng Ye, Shicong Ruan, Bei Zhong, et al. (+38)
110 [GO] 2020―Jul―07 SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski
111 [GO] 2020―Jun―23 SARS-CoV-2 infection of the placenta Hillary Hosier, Shelli F. Farhadian, Raffaella A. Morotti, Uma Deshmukh, Alice Lu-Culligan, Katherine H. Campbell, et al. (+30)
112 [GO] 2020―Jun―11 Early safety indicators of COVID-19 convalescent plasma in 5,000 patients Michael J. Joyner, R. Scott Wright, DeLisa Fairweather, Jonathon W. Senefeld, Katelyn A. Bruno, Stephen A. Klassen, et al. (+30)
113 [GO] 2020―May―28 Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Manuela Capone, Anna Vanni, Michele Spinicci, et al. (+23)
114 [GO] 2020―May―28 New York City COVID-19 resident physician exposure during exponential phase of pandemic Mark P. Breazzano, Junchao Shen, Aliaa H. Abdelhakim, Lora Dagi Glass, Jason Horowitz, Sharon X. Xie, et al. (+3)
115 [GO] 2020―May―27 COVID-19, microangiopathy, hemostatic activation, and complement Wen-Chao Song, Garret A. FitzGerald
116 [GO] 2020―May―11 Clinical trials for COVID-19 should include sex as a variable Evelyne Bischof, Jeannette Wolfe, Sabra L. Klein
117 [GO] 2020―Apr―30 Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists Maximilian F. Konig, Michael A. Powell, Verena Staedtke, Ren-Yuan Bai, David L. Thomas, Nicole M. Fischer, et al. (+12)
118 [GO] 2020―Apr―30 Prototype pathogen approach for pandemic preparedness: world on fire Barney S. Graham, Kizzmekia S. Corbett
119 [GO] 2020―Apr―24 Panic prescribing has become omnipresent during the COVID-19 pandemic Arthur L. Caplan, Ross Upshur
120 [GO] 2020―Apr―07 Deployment of convalescent plasma for the prevention and treatment of COVID-19 Evan M. Bloch, Shmuel Shoham, Arturo Casadevall, Bruce S. Sachais, Beth Shaz, Jeffrey L. Winters, et al. (+21)
121 [GO] 2020―Apr―06 Kidney diseases in the time of COVID-19: major challenges to patient care Hamid Rabb
122 [GO] 2020―Apr―03 The COVID-19 pandemic and research shutdown: staying safe and productive M. Bishr Omary, Jeetendra R. Eswaraka, S. David Kimball, Prabhas V. Moghe, Reynold A. Panettieri, Jr., Kathleen W. Scotto
123 [GO] 2020―Mar―30 COVID-19 threatens health systems in sub-Saharan Africa: the eye of the crocodile Elijah Paintsil
124 [GO] 2020―Mar―27 Clinical and immunologic features in severe and moderate Coronavirus Disease 2019 Guang Chen, Di Wu, Wei Guo, Yong Cao, Da Huang, Hongwu Wang, et al. (+14)
125 [GO] 2020―Mar―27 SARS-CoV-2: A Storm is Raging Savannah F. Pedersen, Ya-Chi Ho
126 [GO] 2020―Mar―22 Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic Rexford S. Ahima, Sarah Jackson, Arturo Casadevall, Gregg L. Semenza, Gordon Tomaselli, Kathleen L. Collins, et al. (+3)
127 [GO] 2020―Mar―13 The convalescent sera option for containing COVID-19 Arturo Casadevall, Liise-anne Pirofski
 [1] 

127 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.018 sec